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The term managed care connotes a commitment to
improving the delivery of health care. Most of the U.S.
population receives its health care through some form of
managed care (1). Thus, managed-care organizations have an
enormous potential to affect the incidence and management of
infectious diseases in their patients. Health care-associated
infections, which are common, serious, and costly adverse
outcomes of medical care, have been identified by a recent
Institute of Medicine Report as among the most pressing
problems of medical care (2).
The potential for managed-care organizations to improve
prevention and management of infections derives from four of
their defining characteristics. Such organizations are
responsible for defined populations in all health-care settings
and for the overall health (including health promotion and
disease prevention) of their members; they create and use
detailed information about their members, their health
status, and the medical care they received (although this
information is usually not complete, it is typically more
comprehensive than that available from other sources); and
they are able to make systemwide changes in care, including
disseminating guidelines, supporting interventions to
improve outcomes, feeding back actual performance data to
providers, and setting standards. In each of these respects,
managed-care organizations resemble traditional public
health agencies, which have played an important role in
reducing health-care associated infections.
Managed care’s population base and health system
strengths, combined with its involvement in the delivery of
care to specific persons, create the opportunity to use new
capabilities and resources to address healthcare-associated
infections. Since this opportunity is still largely unrealized,
there are relatively few directly relevant examples. The
following three, dealing with prevention of neonatal group B
streptococcal infection, surveillance for tuberculosis (TB), and
surveillance for postoperative infection, illustrate ways in
which managed care can contribute to the prevention or
control of serious infections. Although the first two examples
are not health care-associated per se, health-care epidemiolo-
gists are often involved in hospitals’ programs to prevent,
identify, manage, and report them.
Examples of Managed-Care Organizations’
Contributions to Prevention and Control
of Infectious Diseases
Neonatal Group B Streptococcal Infection
Adoption of guidelines developed by the Centers for
Disease Control and Prevention (CDC), the American
Academy of Pediatrics, and the American College of
Obstetrics and Gynecology has led to a profound reduction in
the occurrence of early onset neonatal Group B streptococcal
infection (3). These guidelines changed the recommended
date for screening pregnant women for vaginal or rectal
carriage of group B streptococcus to weeks 35 to 37 of
pregnancy, instead of the second trimester. The guidelines
also recommend initiating prophylaxis at least 4 hours before
delivery. Although the impact of these and other aspects of the
guidelines is evident (3), their implementation poses new
challenges to the health-care system. For example, ensuring
effective communication between the physician’s office, the
microbiology laboratory, and hospital is essential, since the
35-to 37-week screening cultures are usually performed in
obstetricians’ offices, while the culture results are needed
promptly in the hospital to guide management before
delivery. This and other challenges have meant that the
guidelines are imperfectly implemented in some settings and
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that developing systems that monitor adherence to guidelines
is difficult.
Group Health Cooperative of Puget Sound, working in
collaboration with CDC, demonstrated the potential for rapid
implementation of these guidelines (4). The managed-care
organization’s obstetricians and administrative staff created
systems that facilitated a shift from their prior practice of
performing screening cultures at the end of the second
trimester of pregnancy to weeks 35 to 37 (Figure 1). Working
in conjunction with hospital personnel, they created systems
to speed communication of these culture results to the
obstetrical services and made other changes in hospital
procedures that led to a sharp increase in the proportion of
culture-positive women who received antibiotics at least 4
hours before delivery, with no commensurate increase in
antimicrobial-drug administration to women who were not
colonized with group B streptococcus (Figure 2). This example
shows the ability of a managed-care organization to enhance
the dissemination of guidelines, improve coordination of care,
and monitor adherence to guidelines. This form of
coordination is most straightforward in staff model managed-
care organizations, such as Group Health Cooperative, but
other types of managed-care organizations can use some
elements of this approach.
TB Surveillance and Management
A second example illustrates collaboration between
managed-care organizations, clinicians, and public health
agencies. Both providers and microbiology laboratories are
required to report TB to departments of health. However,
there is no effective mechanism to assess the completeness of
clinicians’ reporting of cases when no positive laboratory
culture exists. In Massachusetts, a large managed-care
organization examined its electronic diagnosis and treatment
data, in conjunction with review of the medical records of
patients with diagnoses or treatments consistent with TB.
When data from the managed-care organization were
compared with public health department records (5), 78% of
cases were found by both, but the managed-care data revealed
an additional 18% of reportable cases previously unknown to
the public health department. Most of these cases had no
positive culture, and therefore no laboratory-based reports
had been generated.
Two additional notable findings emerged from this study.
Although the managed-care organization had a rich array of
data types available, pharmacy dispensing data alone proved
to be the most useful information for identifying patients with
active TB, almost all of whom were identifiable because they
received at least two anti-TB drugs. Because these drugs are
not often used for other purposes, it proved unnecessary to
impose further conditions, such as requiring the drugs to be
dispensed repeatedly or to be dispensed at the same time. In
practice, the drugs were usually dispensed repeatedly and at
the same time.
In addition, assessing the frequency and amount of
dispensed drugs identified several persons who were poorly
compliant with their treatment regimen, but who had not
been recognized as such by their clinicians (6). If this result is
confirmed in other settings, monitoring the dispensing of
drugs for anti-TB therapy may become an important adjunct
to TB surveillance and control programs. This investigation
could only have been performed effectively in a managed-care
setting, where access to diagnosis and treatment data and
medical records existed. However, it produced a result that is
applicable to other health-care settings in which there is only
automated pharmacy data. In principle, this type of reporting
could be performed by individual pharmacies or national
pharmacy benefit management companies.
Surveillance for Surgical Site Infection
Collaboration between managed-care organizations and
hospitals has provided convincing evidence that most surgical
site infections are diagnosed after patients are discharged
from the hospital, and many patients never return for care of
the infection to the facility in which surgery was performed
(Figure 3) (7). Further, this trend is increasing as patients are
discharged on, or shortly after, the day of surgery. Because
Figure 1. Stage of pregnancy at which group B streptococcal
screening specimen was obtained. A prompt shift from second
trimester (squares) to weeks 35 to 37 (diamonds) of pregnancy
occurred after new guidelines were introduced  at Group Health
Cooperative of Puget Sound (4).
Figure 2. The proportion of women positive for group B streptococcus
who started intrapartum chemoprophylaxis at least 4 hours before
delivery (squares). For comparison, women without group B
streptococcus (diamonds) are also shown (4).360 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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managed-care organizations have information on postopera-
tive care delivered at all sites, including ambulatory settings
and other hospitals, they can collaborate with hospitals that
perform surgery on their members in conducting postdischarge
surveillance that is otherwise difficult if not impossible to
perform. Current work supported by CDC’s Prevention
Epicenters program is focused on developing methods to allow
efficient use of computerized data to conduct ongoing
surveillance, in conjunction with the hospitals in which
surgery is performed (8). In a study of coronary artery bypass
surgery performed at five hospitals, data from a managed-
care organization identified twice as many surgical site
infections as were identified by hospital-based surveillance
(9). If this work is successfully extended, it should be possible
to use existing automated data to enhance current
surveillance capabilities, allowing uniform, objective surveil-
lance for essentially all surgical procedures. This computer-
based surveillance could supplement or in some cases replace
existing hospital-based efforts that absorb considerable time
and effort of skilled infection control professionals, resulting
in a more complete and accurate monitoring system.
Developing Collaborations Between
 Managed Care and Delivery Systems
Successful collaborations require the identification of
topics that both sides (the hospital-based health-care
epidemiology community and managed-care organizations)
agree are important. Therefore, the first step is to assign
appropriate priority to health care-associated infections so
that both parties can make informed decisions about the
value of collaboration.
Setting Priorities
Managed-care organizations are accountable to the
purchasers of their care. Usually these are employers, who
fund services on behalf of their employees, or government
agencies, who contract for services on behalf of Medicaid
recipients, Medicare beneficiaries, or government employees.
Managed-care organizations are also accountable to their
members, and in some cases to accrediting agencies, such as
the National Committee for Quality Assurance. Thus,
managed-care organizations typically assign priorities on the
basis of several considerations, including impact on members’
health, members’ preferences, cost and cost-effectiveness,
society’s preferences, and quality of care.
In assessing the impact of programs that address specific
health problems, managed-care organizations consider a
problem’s burden of illness to their members, focusing on
common, serious   problems like asthma or osteoporosis. They
also consider the strength of evidence that interventions can
improve health outcome. An example is a standard, adopted
by many managed-care organizations, for using beta-adrenergic
blockers in survivors of myocardial infarction. This standard
was adopted after it was appreciated that use of this relatively
safe and simple treatment was not nearly as common as was
appropriate, despite substantial clinical evidence of benefit.
Managed-care organizations also give priority to their
members’ preferences, even when they have no direct bearing
on health outcomes or when clinical evidence is lacking. These
organizations commit considerable resources to understand-
ing issues that are important to their members and tracking
their members’ satisfaction. In addition to attending to
members’ perception of the quality of care they receive,
managed-care organizations give priority to minimizing
waiting time for appointments, the appearance of offices and
inpatient facilities, and many other issues not directly related
to health status.
Cost and cost-effectiveness are often important drivers of
such organizations’ decisions. These decisions are sometimes
made from the purchaser’s perspective, as in provision of
pneumococcal immunizations for the elderly. At other times,
decisions about cost-effectiveness are made from a societal
perspective. Examples include smoking cessation or
mammography screening programs, which typically yield
their cost savings far enough in the future that the persons
who avoid the adverse health outcomes are unlikely to still be
members of the managed-care organization that paid for the
care. In making these choices, managed-care organizations
typically focus on the 25 conditions that account for nearly
80% of health-care costs (10).
Several dozen quality-of-care benchmarks are repre-
sented in managed-care organizations’ accreditation stan-
dards (11). Examples include mandated performance with
regard to childhood and adult immunization programs,
cancer screening, diabetes care, substance abuse and mental
health, and prenatal care.
Data Issues
Collaborations between managed-care organizations and
the health-care epidemiology community are most likely to be
successful when the managed-care organizations take
advantage of their enrollment and demographic information,
pharmacy dispensing data, and claims files. Such information
is usually available in electronic databases and is used most
often. Work with these data typically involves relatively small
marginal costs, once the programs to create them are
developed. In contrast, it is typically quite difficult for
managed-care organizations to provide information from
noncomputerized records, such as office records. Similarly,
information on care that is delivered in hospitals or other
Figure 3. The proportion of postoperative surgical site infections first
identified before and after discharge from hospital in which surgery
was performed. Light gray bar (Post/unknown) shows infected
patients who did not return to the hospital at which surgery was
performed. The units on the ordinate are percentages of all
procedures (7).361 Vol. 7, No. 2, March–April 2001 Emerging Infectious Diseases
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organizations with which they contract for services may not
be easily available unless these services generate an itemized
bill for payment. For example, a managed-care organization
would have information on intravenous antimicrobial-drug
therapy delivered by a home-care company if the managed-
care organization were charged for individual medications,
but not for the same treatment if the charge for drugs were
bundled into an overall medication administration fee.
Rationale for Collaborations
Benefit to Managed-Care Organizations
Health care-associated infections merit the attention and
effort of managed-care organizations according to the criteria
noted above because these infections are common, they incur
substantial illness and costs, and effective prevention
methods exist but are currently unevenly applied in different
health-care settings.
The Institute of Medicine Report highlighted postopera-
tive infection as one of the most important categories of
adverse events associated with medical care (2). One reason
the burden of these infections is difficult to appreciate is that
the impact of the adverse event is often “lost” in the overall
outcome of the condition being treated. Thus, the fact that
almost 20% of patients require >9 days of antibiotic therapy
because of confirmed or suspected infection after coronary
artery surgery is not ordinarily a separately identified
outcome of this procedure. However, the total cost of these
infections in inpatients alone is estimated to be several billion
dollars per year. Additionally, costs of infections that occur
outside the hospital have not been adequately measured.
Reductions in the occurrence of these infections could
contribute to decreasing both illness and costs of care.
Evidence suggests that carefully implemented programs
to prevent these infections are effective. Examples include
reductions in bloodstream infections in intensive care units,
postoperative surgical site infections, ventilator-associated
pneumonias, and urinary tract infections. An additional
reason that infection control programs merit the attention of
managed-care organizations is that they are often the best
organized and most effective quality improvement and error
reduction programs in many hospitals. The National
Nosocomial Infections Surveillance study has demonstrated
how coordinated but decentralized systems can collect
essential data about quality of care and make meaningful
improvements in outcomes (12). Support of infection control
programs in hospitals, nursing homes, and other facilities
would create opportunities for managed-care organizations to
engage more directly in the care provided by these facilities.
Benefit to Infection Control Programs
Managed care can contribute to infection control
programs in several ways. It can help make infection control
a priority for the entire health-care industry by jointly
developing quality benchmarks with hospitals, nursing
homes, and other components of the delivery system. The
current interest in reducing medical errors can be an
important foundation for such work. Managed care can use
both its data and its ability to coordinate systemwide
interventions to collaborate in research. Examples include
better assessment of the epidemiology, risk factors, and
consequences of health care-associated infections, as well as
assessment of surveillance and prevention methods.
Managed care can also have an impact through its
considerable ability to bring about change in systems of care.
The remarkable shift in the timing of group B streptococcus
screening to a different stage of pregnancy in a single staff
model managed-care organization demonstrates this poten-
tial. Managed care can play an important role in improving
surveillance for these infections by contributing data about
care delivered outside hospitals and integrating data across
hospitals and other delivery sites. It can also assist in the
implementation of infection control programs, especially in
delivery sites such as physicians’ offices, which currently
have little organizational framework in which to develop or
monitor such systems.
The Path to a More Robust Managed Care:
Infection Control Collaboration
To take advantage of the potential benefits to patients,
health-care epidemiologists need to strengthen the rationale
for managed-care organizations to recognize the importance
of health care-associated infections and the potential benefits
of improved infection control programs. Most managed-care
organizations, like other parts of the delivery system, are fully
extended, so the addition of infection control priorities will
require them either to displace an existing quality benchmark
activity or to expand their roles, which will necessitate
passing on new costs to their purchasers.
Both national and local discussions will be required to
make the case for infection control collaborations. Nationally,
the infection control parties best positioned to articulate
overall themes and identify specific areas for collaboration
are CDC, the Society of Healthcare Epidemiologists of
America, and the Association for Professionals in Infection
Control and Epidemiology (APIC). In the managed-care
arena, the American Association of Health Plans, the Health
Insurance Association of America, the Blue Cross Blue Shield
Association, and the managed-care organizations with
nationwide memberships are logical participants in these
discussions. Other participants in discussions should include
accrediting agencies, such as the National Committee on
Quality Assurance and the Joint Commission on Accredita-
tion of Healthcare Organiations, and purchasers, such as the
Washington Business Group on Health, the National
Business Coalition on Health, and the Health Care Financing
Administration. Local discussions between individual health-
care facilities and the managed-care organizations with
which they work will proceed more quickly within the context
of a framework that emerges from national discussions.
Developing explicit technical standards for collecting and
reporting infection surveillance data will also be important.
This is necessary both to ensure that meaningful and
interpretable information is collected and to allow the
efficient development and dissemination of programs to
perform the required work. This strategy has proved useful
for other managed-care benchmarking activities, and it
should be extended to the managed-care infection control
arena. The actual work of creating technical standards is
likely to require working groups with broad representation
and deep technical expertise. Issues that  need to be addressed
include relatively straightforward ones of data availability,
definitions, and reporting standards, plus some that will
address new issues, such as the value of aggregating data
across managed-care organizations and  development of
performance benchmarks.362 Emerging Infectious Diseases Vol. 7, No. 2, March–April 2001
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Finally, it will be important to recognize that both parties
to this discussion are evolving rapidly, as is health care itself.
This means there will be a need for sustained engagement
between managed care and health-care epidemiologists.
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